[Corrigendum] Synergic effect between 5‑fluorouracil and celecoxib on hypoxic gastric cancer cells
Affiliations: Department of Gastroenterology, Qilu Hospital, Shandong University, Jinan, Shandong 250012, P.R. China, Department of Gastroenterology, Affiliated Hospital of Weifang Medical University,Weifang, Shandong 261031, P.R. China, Blood Bank, Affiliated Hospital of Weifang Medical University,Weifang, Shandong 261031, P.R. China, Department of Pharmacology, Weifang Medical University, Weifang, Shandong 261053, P.R. China, Department of Parasitology, Weifang Medical University, Weifang, Shandong 261053, P.R. China
- Published online on: August 2, 2021 https://doi.org/10.3892/mmr.2021.12332
- Article Number: 693
Copyright : © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
This article is mentioned in:
Mol Med Rep 11: [Related article:] 1160-1166, 2014; DOI: 10.3892/mmr.2014.2783
Following the publication of the above article, the authors have realized that Fig. 2 was published with an incorrect data panel: Essentially, Fig. 2D was erroneously selected from the representative images of the Fig. 1C data group during figure compilation.
Adenosine triphosphate-binding cassette sub-family G member 2 expression in each group by immunocytochemistry (magnification, ×400). (A) 5-fluorouracil group; (B) celecoxib group; (C) combination group; and (D) hypoxia control group
The authors were able to locate their original data, and the corrected version of Fig. 2, featuring the corrected data panel for Fig. 2D, is shown below. All the authors agree with this Corrigendum, and are grateful to the Editor of Molecular Medicine Reports for allowing them to publish it. The authors also regret that this inadvertent error was included in the paper, even though it did not substantially alter any of the major conclusions reported in the study, and apologize to the readership for any inconvenience caused.